Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
This intro outlines the cheapest index funds for retirement accounts in 2024 and explains how to balance cost with performance and risk.
24,180 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
JPMorgan Chase moves to a two-person succession test by naming Doug Petno and Troy Rohrbaugh co-presidents, laying th...
Apple sticks to an asset-light model with robust buybacks, while Microsoft escalates capital spending to fuel AI and ...
NovaCore Technologies enters the second half of 2026 with a multi-year backlog, AI revenue momentum, and cloud growth...
Chip shares jumped as risk appetite returned to markets, with Intel and AMD leading a broader move higher on AI infra...
Comcast weighs splitting NBCUniversal from its cable and broadband unit to unlock value. History shows media spinoffs...
NVIDIA is accelerating its on-device AI push, signaling a potential TAM expansion as edge computing moves from theory...
The crypto market braced for headlines as Circle faced talk of an open USD threat. Analysts argue the pullback in CRC...
With Netflix's investor update looming, investors wonder whether to buy before the release. This guide breaks down st...
June payroll gains undershot forecasts, with revisions cooling prior months and participation slipping. The report le...
Fans are feeling the pinch as prices rise for both stadium seats and bar stools. A new survey shows a growing split i...
The Bank of England’s digital pound project has collided with political finance scrutiny, turning a tech plan into a ...